ADDI.OB on the move.
I'm not sure why, but chart looks nice...
Any opinions ?
Just broke 200ma. Looks strong.
Resis: 0.04/0.045. Then clear skies.
Trying to dig a bit more on the company... I love the chart, but I can't buy without knowing a bit more about it ;)
Theirs Bussiness sumary looks nice, and quite original ;)
QuoteBusiness Summary
Addison-Davis Diagnostics, Inc. is a developer, distributor, and marketer of Bio-Med testing and Nutracutical Beverage Products. The Company's first product to market is Nico Water, a patented odorless and tastless water-based nicotine product targeted to smokers for when they shouldn't or can't smoke (around children or nonsmoking environments). Nico Water will be the first nicotine beverage on the market and will be sold in 8 and 16.9 oz. bottles. The Company has been involved in the Research and Development of proprietary products and programs for business and government use to educate and limit liability of employee drug use, sexual harassment and work place discrimination.
* Nico Water will be the first nicotine beverage on the market. This patented product is covered under U.S. Patent Number 6,268,386 and has been assigned to the Company for its duration in the United States and worldwide distribution. This is a broad-based fundamental patent that provides for several new products over the next 2 years.
I'm a smoker... and I would be a buyer of this product ;)
Outstanding Shares: 5.2M
Market Cap: 323k
News:
- http://biz.yahoo.com/iw/050714/090815.html
- http://biz.yahoo.com/iw/050712/090565.html
I've to dig a bit more...
I'm in. Thx Ramsburg(applaud) I have been looking for a chart like this one for a long time ;)
I've gotten filled @.035-.039... not sure what my avg is yet.
lets rock >:D
news yesterday:
http://biz.yahoo.com/iw/050714/090815.html
WESTLAKE VILLAGE, CA--(MARKET WIRE)--Jul 14, 2005 -- Addison-Davis Diagnostics, Inc. (OTC BB:ADDI.OB - News) is pleased to announce that they will be initiating their strategy of targeting corporations with its "Drug Stop" product. The "Drug Stop" product has received a FDA 510(K) Clearance as well as a FDA clearance for sale to the Over-The-Counter market.
I am in too bought at 0.033
Ready to fly ;)
In at $0.37 - chart looks good, I think it may be a double. >:D
I'm not buying more pennies for a while rams, but if this helps: ADDI was on my target list for today.
good luck & applaud
On my wathc list, may buy at the end, or near .03, whichever comes first :)
its hard to buy even on ASK :)
Seems like I have to change my strategy a bit
I wanted to dig a bit more, but at the same time, I'm looking Level2, and it looks like if people start buying it a bit more, I would be left out of the play >:D
I'm in @ $0.037 -> small position (2% of my total)
Let's see how far it will go ;)
Basically, I'm just paying to watch if tomorrow will be a continuation candle ;)
In at .037
does this have potential, or is it a 1 day P&D like PLNI?
ADDI has a very low market cap, this recent news may have a true impact on their financials, and I guess that's the bet speculators are playing now.
Their business plan is nice ;) And the chart suggests continuation.
Of course, theres a lot of risk on this play. Please do your own DD, and in case you buy, take only a very small position.
best regards !
The stock was mentions on yahoo's shakerZ and moverz site. Could explain the move. I was going to buy but ive seen what happens to stocks on that sight when you cant explain the move.
We bought the stock by chart :)
Anyway your choice.
Applaud Ramsburg for another nice pick.
The stock moved due to this news
http://biz.yahoo.com/iw/050714/090815.html
nice action...
bid? what bid?
Wow, what a move. I feel really stupid for selling at $.058 now. :'(
i missed this one . but i have to applaud ramsburg for his great pick and elite for the g-pattern! >:D
hit 200% intraday! how many stocks can do that!
looking forward to next g-pattern find , and i guarentee i wont miss it! >:D
cheers
damn eliteg......your really good at pickin....i just ain't got enough free cash to trade...don't want to sell hisc...i'll wait for a pullback...throwing you another bone (applaud)...
I have to applaud my bro Ramsburg again for bringing this to my attention...what a team eh? ;D :o
Quote from: 52 windsor deluxe on July 18, 2005, 11:46:49 AM
damn eliteg......your really good at pickin....i just ain't got enough free cash to trade...don't want to sell hisc...i'll wait for a pullback...throwing you another bone (applaud)...
Quote from: eagerlearner on July 18, 2005, 11:40:34 AM
i missed this one . but i have to applaud ramsburg for his great pick and elite for the g-pattern! >:D
hit 200% intraday! how many stocks can do that!
looking forward to next g-pattern find , and i guarentee i wont miss it! >:D
cheers
thx yo...Ramsburg and I will be looking for the next g-pattern you can be sure. >:D
eliteg/ramsburg,
can you please elaborate on the G pattern?
thanks!
and oh! congrats on a solid pick!
g-pattern discussion starts on pg3, reply #43,
http://www.3stocksonfire.org/trading/index.php?topic=1374.30
very excited about it...pattern first brought up in the soon to be legendary 3stocksonfire.org trading forum!! 8)
I decided to sell all my ADDI. I got 1/2 @ .064 and 1/2 @ .080(i swear i just missed a dime) a 95% gain from my buy point and many more % from the trigger point!!
I know looking at the pattern it can go for more. It has the volume and the action for it...but while the g-pattern is still in test I dont mind taking 95% profits, >:D. Lets see what becomes of it.
Goodluck to those remaining. :)
applaud both ramsburg and elite. Still holding my shares :)
Hi do you have a exit plan for this one ??? It went up so quick and fast what would be a general exit price ?? TIA
Quote from: yuyjust on July 18, 2005, 12:45:36 PM
Hi do you have a exit plan for this one ??? It went up so quick and fast what would be a general exit price ?? TIA
thats the tough thing with these monsters...I think stocky will end up with some huge gains on this one and yes I'm kinda jealous of his patience ;) but let me tell you the feeling that is worst of all is seeing a gigantic gain become a big loser and these pennies can totally flip on you. To me its about time frame. 100% in 1 day. Yessir I will definately take profits...and yes while its still going up!
elite, I am out now, but I started with a very small position in this one >:D
and very happy that G-pattern worked. :)
For me even 10% profit a day works as I took with KOSN and ran away. Can't applaud you again, have to wait another hour
great trade stocky :o (applaud)
on to the next one ;)
mannnnnnn its at a dime now....geeeeeeeeeeez... i know i know let it go... :-X
If history is any clue then BTSI, MMIC and host of other big one day movers has crashed the following day or even worst by 3 pm. There are still couple of hours left for this play and it may even go to new high of day. But for those who had been in ADDI early it may be time to let it go. Jumping back in may not help :) More risky.
Hi guys ;)
I'm glad this pick is working great ;)
I've sold 1/2 position @ $0.09 (+143% from my entry price), and no mather what happens till the end of the session, I'll hold the rest of the position... I've a great felling about the next opening price ;)
I hope you all make at least 1 bag on this one ;) But I want another one with the «free» shares ;)
Try HISC :) for some free booty
From now own ,I would like to be notified when I miss a play! ;D
HOW DID I MISS SEEING THIS PICK? :-\
How high is HISC supposed to go...i kept watching it all day..thinking ok..its not going to go higher..but, steadily up it goes...i mean..can i still jump in at near .13?
i know everybody is big on HISC and it looks great..but is it really too late now?
thanks
julia
just terrified of buying something at the high to watch it go down...i have that effect on stocks.
:( u missed
No problem there will be many. Just follow four guys on the pennies:
elite, rams, J.B and dave
That may be the simplest startegy. Worked for me though :)
Julia, I will not be buying at this level, but the reason is that I already have my hands full. Its really difficult to predict how much gas is left in a penny. My advice will be NOT TO CHASE and instead look for some other. picks.
Sorry my message above was for STOCKY
Quote from: stocky on July 18, 2005, 01:38:48 PM
Try HISC :) for some free booty
thanks!
julia
thanks Stocky..ur probably right...better not to risk it now.
thanks,
julia
ADDI...... Excellent blast off, excellent support volume behind this stock, Look for temp top around .12 -.15 area, this was at one time a "SUPER" stock. I still see this stock retesting very shortly the .05 - . 06 area, before it can go much higher..........If the volume continues at this level or greater, the stock could go up the the .15 area pretty easy. But what the heck....free stock shares are a nice item to have in your pocket....Right? Happy Trading
Bill the Bull
Is there any chance for ADDI to go up again to above 0.1 in the short term ? How much volume is necessary for this stock to make a significant move ?
Thanks
Anybody still holding this beauty ? >:D
I gave up about 2 hours ago, did not think it had any juice left. Can it still go higher then 0.1 ?
looks great Ramsburg ;D
stoked6...no one can say for certain but it looks to be heading higher..strange question
Quote from: stoked6 on July 20, 2005, 12:49:30 PM
I gave up about 2 hours ago, did not think it had any juice left. Can it still go higher then 0.1 ?
you mean you sold it or gave up in buying it?
I m back :)
I think this one will prove to be G-pattern winner. May be a close near dime will push it lot higher next day.
Quote from: stoked6 on July 20, 2005, 12:49:30 PM
I gave up about 2 hours ago, did not think it had any juice left. Can it still go higher then 0.1 ?
I'm holding half of my stake ;) I think theres some good potential here >:D
its gonna have the volume today 8) >:D
EliteG,
Are you still in?
I wish I could post a Metastock Chart on this one... But this is real good stuf ;)
We'll probably watch another price attack to the last highs... the volume is very strong... I just love it ;)
Hope you guys are still catching this move ;) Anyway, theres more like this one ready to take off soon ;)
ADDI just needs a bit more time, but I'm almost sure it will break 0.12 and will have big ride.
nice volume !
What happened to it? :o
Ramsburg, EliteG, are you guys still in?
I closed my position yesterday near dime again. To me this baby need to come closer to g1 which it has not done so far. Though I am bullish on ADDI. Will look to establish position near 0.45 to .055 if the chance arises.
Quote from: drexler on July 15, 2005, 02:20:58 PM
does this have potential, or is it a 1 day P&D like PLNI?
BOOM! :o
HEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEELP!!!!!
My biggest short fall ever! 40% in two trading days. :'( :'( :'(
I'm holding 1/3 of my stake.
best regards,
For now, this is a bullish candle... ;)
After a big speculative ride, and if I believe on the true potential behind the move, I usually don't sell my entire position... That's what I did on ADDI... first I've sold ½ of my stake @ 0.09 then a bit more, and I stay holding 1/3 of my initial position... I do this to fell the stock from an inside point of view, but without the risk of hurting myself, because the risk is virtually zero on my pocket...
9 sessions since the «BIG» move... And ADDI is still near the highs of the move (the real highs were mostly quick spikes, and not so tradable prices)...
This is very strange... take BLYC, AMRE, etc a an example... Speculations moves based on soft ground...
I don't know exactly what's happening, but maybe we really have some upside potential here... otherwise, this stock should already be near the G-Spot zone, no way a 12 bagger could hold 9 sessions without a significant correction if it was only a big pump and dump...
This way, I have reasons to believe that something big may be on the horizon... I'm not going to increase my position, but I'll completely going to forget about my 1/3 stake I still have on this penny, and come back on a few weeks / months to watch the chart again ;)
Since I'm mostly a technical trader, I would appreciate any fundamental opinions on this one !
PS: I'm risk free on this one, but I must remember that this is VERY HIGH risk territory over here, make you own DD please ! This stock could go down 50% 70%, and I would be completely cool with that, take that in mind before making a commitment on this penny !
Best regards !
For more information please visit our website www.addisondavis.com or contact Matt Maguire 1-866 THE APPL(E).
The same Consulting Firm that represents HISC.
I'm away from office, can anyone post a chat ? it's forming a nice triangle !
Yes...
Ignoring highs and spikes, we can plot a nice Ascending Triangle...
Volume bar today, could be considered Bullish, showing that money is coming back to this stock on a rising day...
I'm looking forward for tomorrow's session ;)
Regards !
Hi !
Addison-Davis Receives $750,000 USD to Finance "Parents' Tool" Drug Test Program
Sep 23, 2005 8:30:00 AM
WESTLAKE VILLAGE, CA -- (MARKET WIRE) -- 09/23/05 -- Addison-Davis Diagnostics, Inc. (OTC BB: ADDI) is pleased to announce that they have received funding from their $750,000 financing.
The proceeds from the funding will be utilized to further its over the counter sales program for the "Parents' Tool" Drug Test Program and its Drug Stop product with the goal of a national distribution campaign. Addison-Davis will also be implementing the "Parents' Tool" interactive web portal which will allow parents to log on to chat, look up information, find local programs, and even post blogs all designed to help keep their children drug-free.
"We are very excited about getting this web portal up and running. The monies we received will enable us to execute our business plan and produce real results for our shareholders," stated Edward W. Withrow III, CEO of Addison-Davis.
The "Parents' Tool" Drug Test, a self-contained NIDA (National Institute of Drug Abuse) 5-panel drug test is to be marketed by national retail chains throughout the United States. The "Parents' Tool" drug test will screen for Amphetamines (Crystal Meth), Cocaine, Opiates, Phencyclidine (PCP) and Marijuana (THC
Hi !
ADDI - UP 26%
(//)
Good luck.
Evgeny.
Hi !
MA (50) - 0.051
MA (200) - 0.036
Bullish Engulfing !
(//)
Good luck.
Evgeny.
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
Commission File Number 000-25022
NOTIFICATION OF LATE FILING
|X| Form 10-K |_| Form 11-K |_| Form 20-F |_| Form 10-Q
|_| Form N-SAR
For Period Ended: June 30, 2005
|_| Transition Report on Form 10-K |_| Transition Report on Form 10-Q
|_| Transition Report on Form 20-F |_| Transition Report on Form N-SAR
For the Transition Period Ended: __________________________________________
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above,
identify the item(s) to which the notification relates:_________________________
PART I
REGISTRANT INFORMATION
Full name of registrant Addison-Davis Diagnostics, Inc.
Former name if applicable
Address of principal executive office 143 Triunfo Canyon Road, Suite 104
City, state and zip code Westlake Village, California 91361
PART II
RULE 12b-25 (b) AND (c)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25 (b), the
following should be completed. (Check box if appropriate.)
| (a) The reasons described in reasonable detail in Part III of this form
| could not be eliminated without unreasonable effort or expense;
| (b) The subject annual report, semi-annual report, transition report on
| Form 10-K, 20-F, 11-K or Form 10-Q, or portion thereof will be filed
|X|| on or before the 15th calendar day following the prescribed due
| date; or the subject quarterly report or transition report on Form
| 10-Q, or portion thereof will be filed on or before the fifth
| calendar day following the prescribed due date; and
| (c) The accountant's statement or other exhibit required by Rule
| 12b-25(c) has been attached if applicable.
<PAGE>
PART III
NARRATIVE
State below in reasonable detail the reasons why Form 10-K, 11-K, 20-F,
10-Q, N-SAR or the transition report portion thereof could not be filed within
the prescribed time period.
The registrant is in the process of preparing and reviewing the financial
information of the Company on a consolidated basis. The process of compiling and
disseminating the information required to be included in the Form 10-KSB for the
relevant fiscal year, as well as the completion of the required review of the
Company's financial information on a consolidated basis, could not be completed
without incurring undue hardship and expense. The registrant undertakes the
responsibility to file such annual report no later than fifteen days after its
original date.
PART IV
OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification
Edward W. Withrow III (805) 494-7838
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of
1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If the answer is no,
identify report(s).
|X| Yes |_| No
(3) Is it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?
|X| Yes |_| No
If so: attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.
For the year ended June 30, 2004, the registrant had revenues of
approximately $192,109 and a net loss of approximately $(7,092,912). For the
year ended June 30, 2005, the registrant currently estimates that it had
revenues of approximately $5,176 and a net loss of approximately $(2,817,226).
Results for this relevant fiscal year remain subject to further adjustment and
actual results may differ significantly from the foregoing estimates.
<PAGE>
Addison-Davis Diagnostics, Inc.
Name of Registrant as Specified in Charter.
Has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: September 29, 2005 By: /s/ Edward W. Withrow III
-----------------------------------
Edward W. Withrow III
Chief Executive Officer
</TEXT>
</DOCUMENT>
SCHEDULE 14C
(RULE 14C-101)
Information Statement Pursuant to Section 14(c) of the Securities Exchange Act
of 1934
Check the appropriate box:
|_| Preliminary Information Statement
|X| Definitive Information Statement
|_| Confidential, for Use of the Commission Only (as permitted by Rule
14c-5(d)(2))
ADDISON-DAVIS DIAGNOSTICS, INC.
(Name of Registrant As Specified In Its Charter)
Payment of Filing Fee (Check the Appropriate Box):
|X| No fee required
|_| Fee computed on table below per Exchange Act Rules 14c-5(g) and 0-11.
(1) Title of each class of securities to which transaction applies:
(2) Aggregate number of securities to which the transaction applies:
(3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (Set forth the amount on which
the filing fee is calculated and state how it was determined):
(4) Proposed maximum aggregate value of transaction:
(5) Total fee paid:
|_| Fee paid previously with preliminary materials
|_| check box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number, or
the Form or Schedule and the date of its filing.
(1) Amount previously paid:
(2) Form, Schedule or Registration Statement No.:
(3) Filing Party:
(4) Date Filed:
<PAGE>
ADDISON-DAVIS DIAGNOSTICS, INC.
143 TRIUNFO CANYON ROAD, SUITE 104
WESTLAKE VILLAGE, CA 91361
INFORMATION STATEMENT
PURSUANT TO SECTION 14
OF THE SECURITIES EXCHANGE ACT OF 1934
AND REGULATION 14C AND SCHEDULE 14C THEREUNDER
WE ARE NOT ASKING YOU FOR A PROXY AND YOU ARE NOT REQUESTED TO SEND US A PROXY
THE ACTIONS DESCRIBED BELOW HAVE ALREADY BEEN APPROVED BY WRITTEN CONSENT OF
HOLDERS OF A MAJORITY OF OUTSTANDING SHARES OF COMMON STOCK. A VOTE OF THE
REMAINING STOCKHOLDERS IS NOT NECESSARY.
September 29, 2005
Westlake Village, CA
This information statement has been mailed on or about September 29, 2005 to the
stockholders of record on July 12, 2005 (the "Record Date") of Addison-Davis
Diagnostics, Inc., a Delaware Company (the "Company") in connection with certain
actions to be taken by the written consent of the majority stockholders of the
Company, dated as of July 12, 2005. The actions to be taken pursuant to the
written consent shall be taken on or about October 19, 2005, 20 days after the
mailing of this information statement.
THIS IS NOT A NOTICE OF A SPECIAL MEETING OF STOCKHOLDERS AND NO STOCKHOLDER
MEETING WILL BE HELD TO CONSIDER ANY MATTER WHICH WILL BE DESCRIBED HEREIN.
By Order of the Board of Directors,
/s/ Edward W. Withrow III
CEO, Director
<PAGE>
NOTICE OF ACTION TO BE TAKEN
PURSUANT TO THE
WRITTEN CONSENT OF MAJORITY STOCKHOLDERS
IN LIEU OF A SPECIAL MEETING OF THE STOCKHOLDERS
DATED JULY 1 2, 2005
To Our Stockholders:
NOTICE IS HEREBY GIVEN that the following action will be taken pursuant to the
written consent of a majority of stockholders dated July 12, 2005, in lieu of a
special meeting of the stockholders. Such actions will be taken on or about
October 19, 2005:
1. The Company will amend its certificate of incorporation to decrease the
authorized amount of common stock from 5,000,000,000 shares to 2,000,000,000
shares.
OUTSTANDING SHARES AND VOTING RIGHTS
As of the Record Date, the Company's authorized capitalization consisted of
5,000,000,000 shares of common stock, par value $.001 per share, ("Common
Stock") of which 36,275,219 shares were issued and outstanding as of the Record
Date. Holders of Common Stock of the Company have no preemptive rights to
acquire or subscribe to any of the additional shares of Common Stock.
Each share of Common Stock entitles its holder to one vote on each matter
submitted to the stockholders. However, because stockholders holding at least a
majority of the voting rights of all outstanding shares of capital stock as of
the Record Date have voted in favor of the foregoing proposal by resolution
dated July 12, 2005, and having sufficient voting power to approve such proposal
through their ownership of capital stock, no other stockholder consents will be
solicited in connection with this Information Statement.
Pursuant to Rule 14c-2 under the Securities Exchange Act of 1934, as amended,
the proposal will not be adopted until a date at least 20 days after the date on
which this Information Statement has been mailed to the stockholders. The
Company anticipates that the actions contemplated herein will be effected on or
about the close of business on October 19, 2005.
The Company has asked brokers and other custodians, nominees and fiduciaries to
forward this Information Statement to the beneficial owners of the Common Stock
held of record by such persons and will reimburse such persons for out-of-pocket
expenses incurred in forwarding such material.
This Information Statement will serve as written notice to stockholders pursuant
to Regulation 14C, and Section 228(e) of the Delaware General Corporation Law.
<PAGE>
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
The following table sets forth, as of July 12, 2005, certain information
regarding the ownership of Addison-Davis Diagnostics, Inc.'s capital stock by:
o each director and executive officer of Addison-Davis Diagnostics,
Inc.;
o each person who is known to Addison-Davis Diagnostics, Inc. to be a
beneficial owner of more than 5% of any class of Addison-Davis
Diagnostics, Inc.'s voting stock; and
o by all officers and directors of Addison-Davis Diagnostics, Inc. as
a group.
Unless otherwise indicated below, to Addison-Davis Diagnostics, Inc.'s
knowledge, all persons listed below have sole voting and investing power with
respect to their shares of capital stock, except to the extent authority is
shared by spouses under applicable community property laws.
Beneficial ownership is determined in accordance with the rules of the
Securities and Exchange Commission and generally includes voting or investment
power with respect to securities. Shares of common stock subject to options,
warrants or convertible securities exercisable or convertible within 60 days of
July 12, 2005 are deemed outstanding for computing the percentage of the person
or entity holding such options, warrants or convertible securities but are not
deemed outstanding for computing the percentage of any other person, and is
based on 36,275,219 shares issued and outstanding.
<TABLE>
<CAPTION>
------------------------------------------------------------------------------------------------------------
Name and Address Percent
Title of Of Amount and Nature Of
Class Beneficial Owners (1) Of Beneficial Ownership Class
------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
Common Stock Edward W. Withrow III 6,188,912 17.38%
------------------------------------------------------------------------------------------------------------
Common Stock Fred De Luca 1,702,266 4.78%
------------------------------------------------------------------------------------------------------------
Common Stock All officers and directors 7,891,178 22.16%
As a group (two persons)
------------------------------------------------------------------------------------------------------------
</TABLE>
(1) Unless otherwise noted, the address for each of the named beneficial owners
is 143 Triunfo Canyon Road, Suite 104 Westlake Village, California 91361.
CHANGE IN CONTROL
To the knowledge of management, there are no present arrangements or pledges of
securities of the Company, which may result in a change in control of the
Company.
<PAGE>
DISSENTER'S RIGHTS OF APPRAISAL
The stockholders have no dissenter's rights of appraisal.
AMENDMENT TO THE ARTICLES OF INCORPORATION
On July 12, 2005, the majority stockholders of the Company authorized an
amendment to the Company's certificate of incorporation to decrease the number
of authorized shares of common stock from 5,000,000,000 to 2,000,000,000. The
Company currently has authorized capital stock of 5,000,000,000 shares of common
stock and approximately 36,275,219 shares of common stock are outstanding as of
the Record Date. The Board believes that the decrease in authorized shares would
still provide the Company with a sufficient amount of authorized shares with
respect to the Company's capital structure.
REASON FOR THE DECREASE IN AUTHORIZED COMMON STOCK
This amendment will not alter the current number of issued shares. The relative
rights and limitations of the shares of common stock would remain unchanged
under this proposal.
The decrease in the number of authorized but unissued shares of common stock
would adequately enable the Company, without further stockholder approval, to
issue shares from time to time as may be required for proper business purposes,
such as raising additional capital for ongoing operations, business and asset
acquisitions, stock splits and dividends, present and future employee benefit
programs and other corporate purposes.
The proposed decrease in the authorized number of shares of Common Stock could
have a number of effects on the Company and it's stockholders depending upon the
exact nature and circumstances of any actual issuance of authorized but unissued
shares. Primarily, the proposed decrease in the authorized number of shares of
Common Stock would more accurately represent, and be more in line with, a
realistic capital structure for a company of our size. Additionally, the
proposed decrease in the authorized number of shares of Common Stock would
prevent a disproportionately high franchise tax by lowering the Company's annual
Delaware franchise tax obligations. The Board believes that the capital
structure modifications and financial benefits offered by the amendment outweigh
any disadvantages.
<PAGE>
ADDITIONAL INFORMATION
The Company is subject to the informational requirements of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), and in accordance
therewith files reports, proxy statements and other information including annual
and quarterly reports on Form 10-KSB and 10-QSB (the "1934 Act Filings") with
the Securities and Exchange Commission (the "Commission"). Reports and other
information filed by the Company can be inspected and copied at the public
reference facilities maintained at the Commission at Room 1024, 450 Fifth
Street, N.W., Washington, DC 20549. Copies of such material can be obtained upon
written request addressed to the Commission, Public Reference Section, 450 Fifth
Street, N.W., Washington, D.C. 20549, at prescribed rates. The Commission
maintains a web site on the Internet (http://www.sec.gov) that contains reports,
proxy and information statements and other information regarding issuers that
file electronically with the Commission through the Electronic Data Gathering,
Analysis and Retrieval System ("EDGAR").
The following documents as filed with the Commission by the Company are
incorporated herein by reference:
1. Annual Report on Form 10-KSB for the year ending June 30, 2004; and
2. Quarterly Report on Form 10QSB for the period ending March 31, 2005
The Company will furnish a copy of any exhibit thereto or other information upon
request by a stockholder to the Company's principal offices at 143 Triunfo
Canyon Road, Suite 104 Westlake Village, CA 91361, attn: Edward W. Withrow III
By Order of the Board of Directors,
/s/ Edward W. Withrow III
CEO, Director
Westlake Village, CA
September 29, 2005
<PAGE>
???
Addison-Davis Diagnostics, Inc. (ADDI) primarily offers diagnostic products. Its diagnostic platform is designed for point-of-care and ambulatory use, and incorporates a single-use disposable specimen collection device. The company's desktop analyzer is capable of detecting data for Myoglobin, CK-MB, Cardiac Troponin-1, and GP-BB, as well as the presence and volume of cocaine. The analyzer can be used in clinics and doctor's offices, as well as in emergency rooms. Addison-Davis is also developing a hand-held mobile multiple assay analyzer that would incorporate the patented technology for specimen collection and provide results for various cardiac and blood-born metrics. In addition, the company engages in the development and commercialization of Drug Stop, a FDA cleared rapid urinalysis test for drugs of abuse, for professional and over-the-counter use. The company was formerly known as QT 5, Inc. and changed its name to Addison-Davis Diagnostics, Inc. in November 2004. Addison-Davis is based in Westlake Village, California. With 66.99 million shares outstanding and an undisclosed short position, there is no longer a failure to deliver in shares of ADDI.
Hi
If ADDI will break 0.0057 $ without problems will go till 0.01 $. ::) I have risked and have bought on 1000 $. I like to buy actions which lay on a floor. >:D
Good luck.
Hi
Look ARON end MFI - accumulation
Hi
Today ADDI has broken 0.0057 $, probably it has begun interesting game ;)
Hi
It is broken 0.006 ADDI goes on the north :o ;)
Good luck
Hi
Good volume ;D
but resistance 0.009 is not broken, if tomorrow ADDI does not break 0.009 I sell (only my opinion) ???
Good luck.
HI
Resistance 0.007, the following 0.009, I think ADDI will try to break resistance (only my opinion) ::)
Hi
Sharp change of the prices, 5 minutes prior to closing.
with-10 % up to +24 %.
it will be possible tomorrow interesting day.
I have bought (only my opinion).
Hi
Support 0.0045
Resistance 0.007
If ADDI breaks support I sell loss (only my opinion) for 20 %.
ADDI +18 %
Probably, probably ;)
ADDI...news out about 15 minutes prior to the close...almost 23 million shares traded the last 10 minutes and the pps rose from .005 to .0068. The news is solid and Monday's open has gapper written all over it. .007 has been a solid resistance point, but I think it might be easily broken on Monday.
http://biz.yahoo.com/iw/060324/0114567.html
Press Release Source: Addison-Davis Diagnostics, Inc.
Addison-Davis Diagnostics, Inc. Announces Federal Agency Distribution Agreement
Friday March 24, 3:44 pm ET
WESTLAKE VILLAGE, CA--(MARKET WIRE)--Mar 24, 2006 -- Addison-Davis Diagnostics, Inc. (OTC BB:ADDI.OB - News) is pleased to announce the signing of a distribution agreement with K&E Logistics & Services to make its DrugStop product available to the United States Federal Government via the General Service Administration (GSA) Federal Supply Schedule programs.
Management views this as a major step forward in product marketing by aligning itself with a fully-functioning outsourced government contracting service department without internal financial overhead burden. We believe that this opens a marketing segment that the Company has had on its radar for some time and now has the opportunity to pursue. With more than 15 years of experience, K&E Logistics & Services provides already-established relationships with key government purchasing and procurement personnel.
About Drugstop:
Food and Drug Administration ("FDA'') 510(k) cleared, Drugstop is a completely self-contained and self-regulating, on-site drug testing product that uses a rapid immunoassay for the qualitative detection of drug metabolites in urine. Drugstop eliminates specimen exposure, reduces the chances of complications in handling, and is the only test available that does not require processing once the sample is collected. Drugstop is designed for human resource professionals for testing a number of different types of drugs including amphetamines, cocaine, opiates, phencyclidine, and cannabinoids.
About K&E Logistics and Services:
K&E Logistics & Services is a full-service government contract consulting organization, specializing in GSA Schedule acquisition. K&E has 15 years experience marketing goods and services to all levels of government. They offer a variety of bid, proposal, administration and support service plans in addition to product Distribution and Representation agreements. Their access to Federal Procurement Agencies includes, but is not limited to, Defense Logistics Agency (DLA), Department of Defense EMALL (DOD EMALL), United States Postal Service (USPS) and Naval Electronic Commerce Online (NECO).
About Addison-Davis:
Addison-Davis is currently focused on supplying quick response diagnostic tests for drugs of abuse that are user friendly, produce fast simple results and are less costly, less problematic and less time consuming through the use of its technology to healthcare professionals, governmental agencies and the workplace environment for drugs-of-abuse. For more information about Addison Davis Diagnostics, Inc visit: http://www.addisondavis.com
This press release contains forward-looking statements that involve risks, uncertainties and assumptions that if they never materialize or prove incorrect, could cause the results of Addison-Davis Diagnostics, Inc. to differ materially from those expressed or implied by such forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including any projections of earnings, revenue, or other financial items, any statements of the plans, strategies, and objectives of management for future operations, any statements concerning proposed new products, services or developments, any statements regarding future economic conditions or performance, statements of belief and any statements of assumptions underlying any of the foregoing. These statements are based on expectations as of the date of this press release. Actual results may differ materially from those projected because of a number of risks and uncertainties, including those detailed from time to time in the reports filed by Addison-Davis Diagnostics, Inc. with the Securities and Exchange Commission. Addison-Davis Diagnostics, Inc. assumes no obligation and does not intend to update these forward-looking statements.
Distributed by Filing Services Canada and retransmitted by Market Wire
Contact:
For further information contact:
Kyle Winthrow
VP Production and Marketing:
Addison-Davis Diagnostics, Inc.
Westlake Village, CA 91361
(805) 494-7838
Quote from: evgeny05 on March 19, 2006, 08:10:19 AM
Hi
Support 0.0045
Resistance 0.007
If ADDI breaks support I sell loss (only my opinion) for 20 %.
Hi
ADDI has not broken 0.0045 and I am the action.
I think, that a mistake will not buy still.
On Monday there will be an interesting day. (only my opinion)
I think this will be the next run up!
::)
Another day for the mm´s to puchase more !!
::)
nice volume!
:o